Table 1 Genetic characteristics of SARS-CoV-2 isolates used in this study.
From: Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses
Virus name | ORF1a | ORF1a | S | NS3 | NS8 | N | GISAID | Lineage | Accession ID | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSP1 | NSP2 | NSP3 | NSP6 | NSP8 | NSP12 | NSP13 | NSP14 | |||||||||||||||
D75 | G82 | H237 | P153 | L37 | M129 | P323 | P504 | Y541 | F233 | D614 | R756 | Q57 | G251 | L84 | R203 | G204 | A205 | T393 | ||||
hCoV-19/Taiwan/NTU01/2020 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | S | – | – | – | – | S | A | EPI_ISL_408489 |
hCoV-19/Taiwan/NTU03/2020 | – | – | – | – | – | – | L | – | – | – | G | – | H | – | – | – | – | – | – | GH | B.1.255 | EPI_ISL_413592 |
hCoV-19/Taiwan/NTU06/2020 | – | – | R | – | F | – | – | – | – | – | – | – | – | V | – | – | – | – | – | V | B.39 | EPI_ISL_422409 |
hCoV-19/Taiwan/NTU013/2020 | E | – | – | L | – | I | – | – | – | L | – | – | – | – | S | – | – | G | I | S | A.3 | EPI_ISL_422415 |
hCoV-19/Taiwan/NTU014/2020 | – | – | – | – | – | – | L | – | – | – | G | L | – | – | – | K | R | – | – | GR | B1.1.119 | EPI_ISL_422416 |
hCoV-19/Taiwan/NTU016/2020a | – | D | – | – | – | – | L | – | – | – | G | – | – | – | – | – | – | – | – | G | B.1 | EPI_ISL_42218 |
hCoV-19/Taiwan/NTU018/2020a | – | – | – | – | – | – | – | L | C | – | – | – | – | – | S | – | – | – | – | S | A.1 | EPI_ISL_447615 |
hCoV-19/Taiwan/NTU027/2020a | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | L | B | EPI_ISL_447621 |
